转氨酶
磷酸西他列汀
化学
组合化学
合理设计
主题(音乐)
立体化学
酶
生物化学
材料科学
纳米技术
医学
内科学
哲学
美学
二甲双胍
胰岛素
作者
Fang-Ying Zhu,Mengyu Huang,Ken Zheng,Xiaojian Zhang,Xue Cai,Lianggang Huang,Zhi‐Qiang Liu,Yu‐Guo Zheng
标识
DOI:10.1016/j.ijbiomac.2023.127348
摘要
The application of (R)-ω-transaminases as biocatalysts for chiral amine synthesis has been hampered by inadequate stereoselectivity and narrow substrate spectrum. Herein, an effective evolution strategy for (R)-ω-transaminase designing for the asymmetric synthesis of sitagliptin intermediate is presented. Since natural transaminases lack activity toward bulky prositagliptin ketone, transaminase scaffolds with catalytic machinery and activity toward the truncated prositagliptin ketone were firstly screened based on substrate walking principle. A transaminase chimera was established synchronously conferring catalytic activity and (R)-selectivity toward prositagliptin ketone through motif swapping, followed by stepwise evolution. The process resulted in a "best" engineered variant MwTAM8, which exhibited 79.2-fold higher activity than the chimeric scaffold MwTAMc. Structural analysis revealed that the heightened activity is mainly due to the enlarged and adaptive substrate pocket and tunnel. The novel (R)-transaminase exhibited unsatisfied industrial operation stability, which is expected to further modify the protein to enhance its tolerance to temperature, pH, and organic solvents to meet sustainable industrial demands. This study underscores a useful evolution strategy of engineering biocatalysts to confer new properties and functions on enzymes for synthesizing high-value drug intermediates.
科研通智能强力驱动
Strongly Powered by AbleSci AI